An Easy-to-Use, Accurate Alternative to the Oral Food Challenge
Attracting the Best Minds
The FARE Innovation Award Diagnostic Challenge will attract the best minds to develop innovative technologies that will lead to a simple point-of-care test to diagnose food allergy
Opportunity to Prove Concept
Opportunity for Funding
What we are looking for

Our goal is to create an alternative for OFC that is highly sensitive and specific and has the potential to identify multiple allergens. The optimal assay is easy to use, does not depend on sophisticated instrumentation, and provides clear results that are reproducible.
The Strategy

The multi-pronged approach allows the exploration of several options simultaneously. There will be maximum flexibility to pursue the most promising options, along with head-to-head comparisons and collaboration across multiple research sites. The strategy is results-driven, offering staged investments with future support contingent on progress.

Staged Data-Driven Approach
Exploratory Phase
March 2021 – April 2023
Assessment Phase
May 2023 – May 2024
Validation Phase
June 2024 – December 2025
Want to Learn More?

Download the FARE Innovation Award Diagnostic Challenge Fact Sheet
Want to Apply?

Download the FARE Innovation Award Diagnostic Challenge Request for Application 2023
FARE is incredibly grateful to the donors of the FARE Innovation Award Diagnostic Challenge

The Naddisy Foundation | The Carter Family | Nestlé Health Science | The Trachte Family | The Hittman Family Foundation | Dr. Louise Matthews and Thomas Flickinger | Wende Fox Lawson and Jim Lawson | Stacy and Ron Klein | Anonymous